We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$127M
AUM Growth
-$4.96M
Cap. Flow
-$4.11M
Cap. Flow %
-3.24%
Top 10 Hldgs %
77.16%
Holding
60
New
1
Increased
9
Reduced
22
Closed
9

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$940K
2
CELG
Celgene Corp
CELG
+$799K
3
JNJ icon
Johnson & Johnson
JNJ
+$289K
4
TROW icon
T. Rowe Price
TROW
+$234K
5
PFE icon
Pfizer
PFE
+$208K

Sector Composition

Rank Sector Weight
1 Healthcare 54.01%
2 Technology 26.21%
3 Communication Services 5.9%
4 Financials 3.54%
5 Consumer Discretionary 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
51
Western Union
WU
$2.04B
$203K 0.16%
9,988
ABBV icon
52
AbbVie
ABBV
$436B
-16,063
Closed -$940K
BA icon
53
Boeing
BA
$182B
-200
Closed -$30K
CNP icon
54
CenterPoint Energy
CNP
$27.5B
-7,500
Closed -$153K
EMN icon
55
Eastman Chemical
EMN
$8.22B
-2,300
Closed -$159K
EOG icon
56
EOG Resources
EOG
$77.8B
-1,600
Closed -$147K
LOW icon
57
Lowe's Companies
LOW
$117B
-2,000
Closed -$149K
RIG icon
58
Transocean
RIG
$5.71B
-3,350
Closed -$49K
SO icon
59
Southern Company
SO
$108B
-2,831
Closed -$125K
LVLT
60
DELISTED
Level 3 Communications Inc
LVLT
-3,609
Closed -$194K

Similar funds

Bourne Lent Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Bourne Lent Asset Management held 60 positions worth $127M, down 3.8% from $132M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Bourne Lent Asset Management withdrew a net $4.11M in Q2 2015, closing 9 positions and reducing 22 holdings. Its most notable exit was AbbVie, an estimated $940K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Bourne Lent Asset Management opened a new position in Gilead Sciences worth $234K.

  • Bourne Lent Asset Management's largest Q2 2015 buy was Gilead Sciences: 2,000 shares worth $234K.
  • Bourne Lent Asset Management added most to Tompkins Financial in Q2 2015, an estimated $111K increase.
  • Bourne Lent Asset Management's biggest Q2 2015 reduction was Celgene Corp, cutting an estimated $799K.
  • Bourne Lent Asset Management fully exited AbbVie in Q2 2015, selling an estimated $940K.
  • Bourne Lent Asset Management's ten largest holdings make up 77% of its $127M portfolio in Q2 2015.
  • Bourne Lent Asset Management opened 1 new position and closed 9 in Q2 2015.
  • Bourne Lent Asset Management's portfolio value fell 3.8% quarter-over-quarter to $127M.

Based on Bourne Lent Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.